MHRAsafety guidance72% confidence
Policy paper: Medicines and Healthcare products Regulatory Agency (MHRA) economic growth goals
Source: MHRA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (ild) as BioMarin Pharmaceutical.
Regulatory Analysis
Goals agreed with the Medicines and Healthcare products Regulatory Agency to clarify how their actions should support economic growth.
Supporting Context
- Therapeutic area
- Pediatrics · Growth Disorders
- Sub-indication
- Ild
Related signal: BioMarin's Study on Growth in Children with Idiopathic Short Stature Underway